Gabapentinoid-related deaths: An alarming global trend or just a special challenge within the long tail of the giant opioid epidemic?
Saved in:
Main Authors: | Udo Bonnet (Author), Volker Auwärter (Author), Norbert Scherbaum (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2022-07-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Gabapentinoids: condemned without sufficient evidence?
by: Udo Bonnet, et al.
Published: (2023) -
A tale of two tails: Not just skin deep
by: Abhijit Dutta, et al.
Published: (2015) -
Characterization of hospitalized patients who received naloxone while receiving opioids with or without gabapentinoids
by: Payal H. Desai, PharmD, BCCCP, et al.
Published: (2021) -
Risk of major adverse events associated with gabapentinoid and opioid combination therapy: A systematic review and meta-analysis
by: Jongsung Hahn, et al.
Published: (2022) -
Opioid use disorder in Germany: healthcare costs of patients in opioid maintenance treatment
by: Jens Reimer, et al.
Published: (2019)